Synthetic biology startup AbSci raises $65M to expand ‘Protein Printing’ tech

Synthetic biology startup AbSci raises $65M to expand ‘Protein Printing’ tech

No comments

AbSci CEO and Founder Sean McClain. (AbSci Photo) Vancouver, Wash.-based biotech company AbSci raised an additional $65 million to help grow its synthetic biology platform. The company’s “Protein Printing” technology is used to discover and manufacture complex biological molecules such as antibodies and insulin. The AbSci platform is composed […]

Click here to view original web page at www.geekwire.com

Any thought?

This site uses Akismet to reduce spam. Learn how your comment data is processed.